News | February 17, 2015

WPE First Proton Center in Europe to Treat with RayStation

First patient treated was four-year-old boy with malignant brain tumor

RayStation, Raysearch, WPE, Germany, proton therapy, radiation

February 17, 2015 — RaySearch Laboratories AB announced that Westdeutsches Protonentherapiezentrum Essen (WPE) in Germany, a subsidiary of University Hospital Essen, has commenced routine clinical operations with the RayStation treatment planning system from RaySearch. The first clinical treatment generated with the help of RayStation was carried out in January 2015 and the first patient was a four-year-old boy with a malignant brain tumor who received radiation therapy for the entire craniospinal volume.

WPE, being the first university-based proton therapy center in Germany with three gantries and one fixed beam line, started treating patients in mid-2013 and has to date treated more than 150 patients with proton beam therapy. The tumor is irradiated with high precision by scanned or scattered proton beams; the radiation dose can thereby be delivered more precisely and as a result, the unwanted dose to healthy tissues is reduced, leading to a risk reduction of treatment-related side effects.

The RayStation functionality specification for WPE spans the entire spectrum of advanced treatment planning such as model-based segmentation, atlas-based segmentation, robust optimization, deformable registration, dose accumulation and treatment adaptation.

Prof. Beate Timmermann, M.D., medical director at WPE, commented: “With RayStation we’re able to manage more types of cancer than before. This gives hope to patients with tumors in the central nervous system or sarcomas among others. A development like this was only possible due to the intense partnership between our doctors and physicists and the staff of RaySearch.”

Prof. mult Eckhard Nagel, M.D., medical director of the University Hospital Essen, added: “We are very proud that WPE is the first proton therapy center in Europe that uses RayStation. This offers us the possibility to help much more patients with cancer than before and opens the way for successful cancer therapies even under difficult conditions.”

For more information: www.raysearchlabs.com

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init